BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 25124036)

  • 1. Human trefoil factor 2 is a lectin that binds α-GlcNAc-capped mucin glycans with antibiotic activity against Helicobacter pylori.
    Hanisch FG; Bonar D; Schloerer N; Schroten H
    J Biol Chem; 2014 Oct; 289(40):27363-75. PubMed ID: 25124036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Double Face of Mucin-Type O-Glycans in Lectin-Mediated Infection and Immunity.
    Morozov V; Borkowski J; Hanisch FG
    Molecules; 2018 May; 23(5):. PubMed ID: 29751628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commercial Porcine Gastric Mucin Preparations, also Used as Artificial Saliva, are a Rich Source for the Lectin TFF2: In Vitro Binding Studies.
    Stürmer R; Harder S; Schlüter H; Hoffmann W
    Chembiochem; 2018 Dec; 19(24):2598-2608. PubMed ID: 30371971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different Forms of TFF2, A Lectin of the Human Gastric Mucus Barrier:
    Heuer F; Stürmer R; Heuer J; Kalinski T; Lemke A; Meyer F; Hoffmann W
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31771101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of the effect of Helicobacter pylori on the expressions of SOX2, CDX2, MUC2, MUC5AC, MUC6, TFF1, TFF2, and TFF3 mRNAs in human gastric carcinoma cells.
    Matsuda K; Yamauchi K; Matsumoto T; Sano K; Yamaoka Y; Ota H
    Scand J Gastroenterol; 2008 Jan; 43(1):25-33. PubMed ID: 18938748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant epithelial expression of trefoil family factor 2 and mucin 6 in Helicobacter pylori infected gastric antrum, incisura, and body and its association with antralisation.
    Xia HH; Yang Y; Lam SK; Wong WM; Leung SY; Yuen ST; Elia G; Wright NA; Wong BC
    J Clin Pathol; 2004 Aug; 57(8):861-6. PubMed ID: 15280409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiological investigation of the gastric surface mucous gel layer of patients with Helicobacter pylori infection by using immunoassays for trefoil factor family 2 and gastric gland mucous cell-type mucin in gastric juice.
    Kubota S; Yamauchi K; Sugano M; Kawasaki K; Sugiyama A; Matsuzawa K; Akamatsu T; Ohmoto Y; Ota H
    Dig Dis Sci; 2011 Dec; 56(12):3498-506. PubMed ID: 21559742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TFF2, a MUC6-binding lectin stabilizing the gastric mucus barrier and more (Review).
    Hoffmann W
    Int J Oncol; 2015 Sep; 47(3):806-16. PubMed ID: 26201258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metaplasia of the duodenum shows a Helicobacter pylori-correlated differentiation into gastric-type protein expression.
    Van De Bovenkamp JH; Korteland-Van Male AM; Büller HA; Einerhand AW; Dekker J
    Hum Pathol; 2003 Feb; 34(2):156-65. PubMed ID: 12612884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of gastric mucin-type O-glycans in the pathogenesis of Helicobacter pylori infection.
    Kobayashi M; Lee H; Nakayama J; Fukuda M
    Glycobiology; 2009 May; 19(5):453-61. PubMed ID: 19150806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barrett's esophagus is characterized by expression of gastric-type mucins (MUC5AC, MUC6) and TFF peptides (TFF1 and TFF2), but the risk of carcinoma development may be indicated by the intestinal-type mucin, MUC2.
    Warson C; Van De Bovenkamp JH; Korteland-Van Male AM; Büller HA; Einerhand AW; Ectors NL; Dekker J
    Hum Pathol; 2002 Jun; 33(6):660-8. PubMed ID: 12152167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha1,4GlcNAc-capped mucin-type O-glycan inhibits cholesterol alpha-glucosyltransferase from Helicobacter pylori and suppresses H. pylori growth.
    Lee H; Wang P; Hoshino H; Ito Y; Kobayashi M; Nakayama J; Seeberger PH; Fukuda M
    Glycobiology; 2008 Jul; 18(7):549-58. PubMed ID: 18458030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assay of human gastric mucin as a natural antibiotic against Helicobacter pylori.
    Fukuda M; Kawakubo M; Ito Y; Kobayashi M; Lee H; Nakayama J
    Methods Enzymol; 2006; 415():164-79. PubMed ID: 17116474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbohydrate-dependent defense mechanisms against Helicobacter pylori infection.
    Kobayashi M; Lee H; Nakayama J; Fukuda M
    Curr Drug Metab; 2009 Jan; 10(1):29-40. PubMed ID: 19149511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Almost all human gastric mucin O-glycans harbor blood group A, B or H antigens and are potential binding sites for Helicobacter pylori.
    Rossez Y; Maes E; Lefebvre Darroman T; Gosset P; Ecobichon C; Joncquel Chevalier Curt M; Boneca IG; Michalski JC; Robbe-Masselot C
    Glycobiology; 2012 Sep; 22(9):1193-206. PubMed ID: 22522599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muc5ac gastric mucin glycosylation is shaped by FUT2 activity and functionally impacts Helicobacter pylori binding.
    Magalhães A; Rossez Y; Robbe-Masselot C; Maes E; Gomes J; Shevtsova A; Bugaytsova J; Borén T; Reis CA
    Sci Rep; 2016 May; 6():25575. PubMed ID: 27161092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diurnal rhythm of the cytoprotective human trefoil protein TFF2 is reduced by factors associated with gastric mucosal damage: ageing, Helicobacter pylori infection, and sleep deprivation.
    Johns CE; Newton JL; Westley BR; May FE
    Am J Gastroenterol; 2005 Jul; 100(7):1491-7. PubMed ID: 15984970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Interaction of
    Clyne M; May FEB
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500233
    [No Abstract]   [Full Text] [Related]  

  • 19. Helicobacter pylori infection promotes methylation and silencing of trefoil factor 2, leading to gastric tumor development in mice and humans.
    Peterson AJ; Menheniott TR; O'Connor L; Walduck AK; Fox JG; Kawakami K; Minamoto T; Ong EK; Wang TC; Judd LM; Giraud AS
    Gastroenterology; 2010 Dec; 139(6):2005-17. PubMed ID: 20801119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trefoil Factor Family (TFF) Peptides and Their Diverse Molecular Functions in Mucus Barrier Protection and More: Changing the Paradigm.
    Hoffmann W
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.